Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Alternative splicing and the evolution of phenotypic novelty.

Bush SJ, Chen L, Tovar-Corona JM, Urrutia AO.

Philos Trans R Soc Lond B Biol Sci. 2017 Feb 5;372(1713). pii: 20150474. Review.

PMID:
27994117
2.

Mendelian Randomization as an Approach to Assess Causality Using Observational Data.

Sekula P, Del Greco M F, Pattaro C, Köttgen A.

J Am Soc Nephrol. 2016 Nov;27(11):3253-3265.

PMID:
27486138
3.

Transcriptome-Wide Analysis Reveals Modulation of Human Macrophage Inflammatory Phenotype Through Alternative Splicing.

Lin J, Hu Y, Nunez S, Foulkes AS, Cieply B, Xue C, Gerelus M, Li W, Zhang H, Rader DJ, Musunuru K, Li M, Reilly MP.

Arterioscler Thromb Vasc Biol. 2016 Jul;36(7):1434-47. doi: 10.1161/ATVBAHA.116.307573. Erratum in: Arterioscler Thromb Vasc Biol. 2016 Nov;36(11):e96.

PMID:
27230130
4.

SUGP1 is a novel regulator of cholesterol metabolism.

Kim MJ, Yu CY, Theusch E, Naidoo D, Stevens K, Kuang YL, Schuetz E, Chaudhry AS, Medina MW.

Hum Mol Genet. 2016 Jul 15;25(14):3106-3116.

5.

Association of HMGCR polymorphism with late-onset Alzheimer's disease in Han Chinese.

Chang XL, Tan L, Tan MS, Wang HF, Tan CC, Zhang W, Zheng ZJ, Kong LL, Wang ZX, Jiang T, Yu JT, Tan L.

Oncotarget. 2016 Apr 19;7(16):22746-51. doi: 10.18632/oncotarget.8176.

6.

Effect of HMGCR genetic variation on neuroimaging biomarkers in healthy, mild cognitive impairment and Alzheimer's disease cohorts.

Cao L, Wang HF, Tan L, Sun FR, Tan MS, Tan CC, Jiang T, Yu JT, Tan L; Alzheimer’s Disease Neuroimaging Initiative..

Oncotarget. 2016 Mar 22;7(12):13319-27. doi: 10.18632/oncotarget.7797.

7.

Effects of rs3846662 Variants on HMGCR mRNA and Protein Levels and on Markers of Alzheimer's Disease Pathology.

Leduc V, Théroux L, Dea D, Dufour R, Poirier J.

J Mol Neurosci. 2016 Jan;58(1):109-19. doi: 10.1007/s12031-015-0666-7.

8.

Role of rs3846662 and HMGCR alternative splicing in statin efficacy and baseline lipid levels in familial hypercholesterolemia.

Leduc V, Bourque L, Poirier J, Dufour R.

Pharmacogenet Genomics. 2016 Jan;26(1):1-11. doi: 10.1097/FPC.0000000000000178.

9.
10.

Association between CETP, MLXIPL, and TOMM40 polymorphisms and serum lipid levels in a Latvian population.

Radovica I, Fridmanis D, Silamikelis I, Nikitina-Zake L, Klovins J.

Meta Gene. 2014 Aug 20;2:565-78. doi: 10.1016/j.mgene.2014.07.006.

11.

Biological knowledge-driven analysis of epistasis in human GWAS with application to lipid traits.

Ma L, Keinan A, Clark AG.

Methods Mol Biol. 2015;1253:35-45. doi: 10.1007/978-1-4939-2155-3_3.

12.

RNA-sequencing analysis of HepG2 cells treated with atorvastatin.

Stormo C, Kringen MK, Lyle R, Olstad OK, Sachse D, Berg JP, Piehler AP.

PLoS One. 2014 Aug 25;9(8):e105836. doi: 10.1371/journal.pone.0105836.

13.

HMGCR is a genetic modifier for risk, age of onset and MCI conversion to Alzheimer's disease in a three cohorts study.

Leduc V, De Beaumont L, Théroux L, Dea D, Aisen P, Petersen RC; Alzheimer's Disease Neuroimaging Initiative., Dufour R, Poirier J.

Mol Psychiatry. 2015 Jul;20(7):867-73. doi: 10.1038/mp.2014.81.

14.

Evaluation of the effect of genetic variation on the relationship between statins, cardiovascular disease and cancer.

Desai P, Jay A, Bock C, Dyson G, Okwuosa T, Simon MS.

Int J Mol Epidemiol Genet. 2013 Nov 28;4(4):183-92. Review.

15.

HNRNPA1 regulates HMGCR alternative splicing and modulates cellular cholesterol metabolism.

Yu CY, Theusch E, Lo K, Mangravite LM, Naidoo D, Kutilova M, Medina MW.

Hum Mol Genet. 2014 Jan 15;23(2):319-32. doi: 10.1093/hmg/ddt422.

16.

Regulation of alternative splicing in obesity and weight loss.

Kaminska D, Pihlajamäki J.

Adipocyte. 2013 Jul 1;2(3):143-7. doi: 10.4161/adip.24751.

17.

Alternative splicing for diseases, cancers, drugs, and databases.

Tang JY, Lee JC, Hou MF, Wang CL, Chen CC, Huang HW, Chang HW.

ScientificWorldJournal. 2013 May 22;2013:703568. doi: 10.1155/2013/703568. Review.

18.

The association of common SNPs and haplotypes in CETP gene with HDL cholesterol levels in Latvian population.

Radovica I, Fridmanis D, Vaivade I, Nikitina-Zake L, Klovins J.

PLoS One. 2013 May 13;8(5):e64191. doi: 10.1371/journal.pone.0064191.

19.

RNAi-based functional profiling of loci from blood lipid genome-wide association studies identifies genes with cholesterol-regulatory function.

Blattmann P, Schuberth C, Pepperkok R, Runz H.

PLoS Genet. 2013;9(2):e1003338. doi: 10.1371/journal.pgen.1003338.

20.

Alternative splicing in the regulation of cholesterol homeostasis.

Medina MW, Krauss RM.

Curr Opin Lipidol. 2013 Apr;24(2):147-52. doi: 10.1097/MOL.0b013e32835cf284. Review.

Supplemental Content

Support Center